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Charcot-Marie-Tooth disease (CMT) is an inherited neuronal disorder,  and is induced by mutations of 
various genes associated with intracellular membrane traﬃc and cytoskeleton.  A large GTPase,  
dynamin,  which is known as a ﬁssion protein for endocytic vesicles,  was identiﬁed as a gene respon-
sible for dominant-intermediate CMT type 2B (DI-CMT2B).  Of these mutants,  the PH domain,  which 
is required for interaction with phosphoinositides,  was mutated in several families.  Interestingly,  the 
expression of a deletion mutant,  551Δ3,  did not impair endocytosis,  but induced abnormal accumula-
tion of microtubules.  Recent evidence has shown that dynamin 2 regulates the dynamic instability of 
microtubules,  and 551Δ3 lacks this function.  We propose a model for the regulation of the dynamic 
instability of microtubules by dynamin 2 and discuss the relationship between dynamin 2 and CMT.
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harcot-Marie-Tooth diseases (CMT) are heredi-
tary motor and sensory neuropathies that aﬀect 
the peripheral nervous system.  The CMT fall into 2 
main groups.  CMT type 1 includes demyelinating forms 
of the disease in which nerve conduction velocities 
(NCVs) are reduced; CMT type 2 includes axonal forms 
in which NCVs are normal,  but conduction amplitudes 
are decreased [1].  There are also dominant interme-
diate (DI) subtypes of CMT,  denoted DI-CMTA,  
DI-CMTB,  DI-CMTC,  and DI-CMTD,  that are charac-
terized by both axonal and demyelinating NCVs 
[2-5].
　 Depending on the gene aﬀected and the type of 
mutation,  functional deﬁcits in either Schwann cells 
or neurons or both lead either directly or via dis-
turbed Schwann cell-axon interactions to axonal atro-
phy and disability.  The genes aﬀected include motor 
proteins,  structural proteins and others [1].  Of these,  
dynamin 2 has been identiﬁed as a gene responsible 
for DI-CMTB [6].  Dynamin is known as a ﬁssion 
protein for intracellular transport vesicles.  Dynamin 2 
is a ubiquitously expressed isoform,  dynamin 1 is 
neuron-speciﬁc,  and dynamin 3 is highly expressed in 
the brain,  testis,  lung and heart [7].  All dynamin 
isoforms are considered to act as ﬁssion proteins 
through their GTPase activity.  Several mutations of 
dynamin 2 were found in CMT patients,  and these 
mutations were concentrated in its Pleckstrin homol-
ogy (PH) domain,  which is required for binding to 
phosphoinositides.
　 Recently,  we reported that dynamin 2 is required 
for the dynamic instability of microtubules,  and a 
dynamin 2 mutant,  which was found in CMT patients,  
impaired its microtubule-associated function [8].  As 
the clinical phenotype was described by others [9],  
we will focus on the function of dynamin and its asso-
ciation with clinical phenotypes.
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Dynamin and Its History
　 The Drosophila melanogaster mutant shibire (shits),  
a temperature-sensitive paralytic mutant,  was known 
[10] long before the discovery of mammalian dynamin.  
The paralysis that occurred in these ﬂies resulted 
from the depletion of synaptic vesicles in neurons.  
Ultrastructural analysis of shits mutant ﬂies revealed 
an accumulation of endocytic pits at the presynaptic 
plasma membrane of the neurons [11] and in other 
cells [12].  Thus,  the linkage between the shibire 
gene in endocytosis have been well established.
　 Mammalian dynamin was originally isolated from 
the bovine brain as a microtubule-binding protein 
[13].  Puriﬁed dynamin bound and interconnected 
microtubules [13] and supported microtubule gliding 
[14].  The amino acid sequence of dynamin,  which 
contained 3 consensus elements characteristic of 
GTP-binding proteins,  suggested that it is a GTPase 
[15].  As suspected,  dynamin showed GTPase activ-
ity,  which is highly stimulated by the presence of 
microtubules [16].
　 Following the identiﬁcation of mammalian dynamin,  
rat brain dynamin and the Drosophila shibire gene 
were cloned and sequenced successively [15,  17],  
and considerably high homology between the primary 
structures of the 2 molecules was revealed (66ｵ 
identity,  78ｵ similarity).  This ﬁnding immediately 
made dynamin a major topic of endocytosis research.  
Soon thereafter,  endocytosis was examined in COS 
and HeLa cells overexpressing mutant dynamin,  and it 
was found that endocytosis was blocked at an interme-
diate stage in these cells [18,  19].
　 Mammalian brain dynamin was exclusively expressed 
in neurons [20],  preferentially after postnatal day 7 
[21].  The neuron-speciﬁc isoform is termed dynamin 
1,  since 2 other isoforms with diﬀerent tissue distri-
butions have been identiﬁed.  Dynamin 2 is expressed 
ubiquitously [22],  and dynamin 3 is highly expressed 
in the brain,  testis,  lung and heart [23].  Dynamin 
isoforms were highly homologous to each other.  The 
molecular mechanisms of dynamin-dependent endocy-
tosis in mammals have been studied using mainly 
dynamin 1 and 2.
Molecular Mechanisms of Dynamin in 
Endocytosis
　 All the dynamin isoforms share 5 signiﬁcant char-
acteristic domains (Fig.  1).  These include a highly 
conserved N-terminal GTPase domain,  a middle domain 
that binds to γ-tubulin [24],  a PH domain that inter-
acts with phosphoinositides such as phosphinositide-4,  
5-diphosphate (PI(4,  5)P2) [25],  and the GTPase-
eﬀector domain (GED).  The proline/arginine-rich 
domain (PRD) at the C-terminus,  which varies consid-
erably between dynamin isoforms,  mediates interac-
tion with various SH3-domain-containing endocytic 
proteins,  such as amphiphysin 1 [26,  27],  endophilin 
[28],  intersectin [29],  and sorting nexin 9 [30].  
Actin-binding proteins,  such as cortactin and Abp1,  
also bind to PRD [31,  32].
　 Dynamin self-assembles,  or assembles with a bind-
ing partner molecule into ring structures in vitro [27,  
33].  Furthermore,  in the presence of liposomes,  
dynamin polymerizes on the lipid bilayer,  deforms the 
lipid membranes into narrow tubules,  and constricts 
the lipid tubules to fragmentation upon GTP-hydrolysis 
[34,  35].  These properties of dynamin strongly sup-
port its role in the ﬁssion process of endocytic pits.  
On the plasma membrane,  dynamin polymerizes into 
rings at the neck of deeply invaginated endocytic pits 
[36],  and by conformational change that coincides 
with GTP hydrolysis,  dynamin rings constrict the 
endocytic pits to ﬁssion [35,  37,  38].  This mecha-
nism of action of dynamin in the ﬁssion process is 
referred to as the pinchase model.  Another model in 
which conformational change of dynamin causes the 
extension of the dynamin spirals to pop oﬀ of the 
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Fig. 1　 Schematic representation of dynamin 2 indicating func-
tional domains and mutation sites found in CMT patients.  The 
illustrated functional domains in dynamin 2 are as follows: GTPase 
domain,  middle domain,  Pleckstrin homology domain (PH),  
GTPase-eﬀector domain (GED) and proline-rich domain (PRD).  The 
role of each domain is described in the text.  The mutation sites are 
based on Claeys et al.  (2009) [9].
endocytic pits,  which is referred to as the poppase 
model,  has been proposed [34].  In either case,  
dynamin functions as a GTP hydrolysis-driven mecha-
noenzyme.  The enzymatic characteristics of dynamin 
GTPase activity that are stimulated by self-assembly 
[39],  by interaction with membrane lipids such as 
PI(4,  5)P2 via the PH domain [40],  or by interac-
tion with a subset of SH3-domain-containing molecules 
via PRD [27] are favorable for these models.
　 The interaction of dynamin with SH3-domain-
containing proteins may represent a mechanism for 
facilitating dynaminʼs ﬁssion reaction with other fac-
tors.  For example,  through the interaction with 
BAR-domain-containing proteins such as amphiphsyin 
or endophilin,  the sensing or inducing of membrane 
curvature by its BAR domain is synchronized with the 
ﬁssion reaction by dynamin [27,  41].  Through the 
interaction of dynamin with ABP1 or cortactin,  actin 
dynamics would take place at the site of endocytosis.  
Treatment with Latrunculin B,  an actin-monomer-
sequestering agent that blocks fast actin polymeriza-
tion,  resulted in inhibition of the ﬁssion reaction,  
which implies the presence of actin dynamics in endo-
cytsis [41].
　 Dynamin 1 is phosphorylated by several kinases 
including PKC and CDK5,  and is dephosphorylated by 
calcineurin.  Endocytosis is enhanced in the presence 
of roscovitine,  a CDK5 inhibitor,  indicating that 
CDK5-dependent phosphorylation of dynamin 1 nega-
tively regulates this process.  CDK5 phosphorylates 
not only dynamin 1 but also amphiphsyin 1,  its binding 
partner in endocytosis,  and the interaction between 
dynamin 1 and amphiphysin 1 is inhibited by the phos-
phorylation [42].
　 Dynamin1 single knockout mice were viable and 
able to form functional synapses in which membrane 
invaginations were accumulated and capped by clath-
rin-coated pits.  Synaptic vesicle endocytosis was 
severely impaired only during strong stimulation but 
resumed eﬃciently when the stimulus was terminated,  
indicating that dynamin 1-dependent endocytosis is 
needed for a high level of neuronal activity to occur 
[43].  In dynamin 1 and dynamin 2 double-knockout 
cells,  actin-nucleating proteins,  actin,  and BAR 
domain proteins accumulate at the base of arrested 
endocytic clathrin-coated pits with long tubular necks.  
These results suggest that dynamin plays a role in 
coordinating the action of these proteins with the ﬁs-
sion reaction induced by dynamin [44].
Cytoskeleton and Dynamin
　 Dynamin is implicated in the formation of actin-rich 
structures,  such as podosomes [45],  invadopodia [46],  
lamellipodia and dorsal membrane ruﬄes [7,  31,  47],  
phagocytic cups [48],  and actin comets [49,  50].  
Consistent with the link between dynamin and the actin 
cytoskeleton in cellular functions,  molecular interac-
tions between dynamin and a variety of actin-binding 
proteins,  including proﬁlin [51],  cortactin [31],  
syndapin [52],  and Abp1 have been reported.  Most of 
these studies emphasize the function of the actin 
cytoskeleton in dynamin-dependent vesicle formation,  
but some indicate the direct involvement of dynamin in 
the regulation of the actin cytoskeleton.  For example,  
dynamin 2 observed in the actin comet is not 
restricted at the vesicle-actin comet interface,  but also 
extends along the length of the comet tails [50].  The 
assembly and remodeling of actin ﬁlaments by dynamin 
2,  through an interaction with cortactin,  has been 
demonstrated by in vitro experiments [53,  54],  and 
this ability of dynamin may be implicated in the regu-
lation of supramolecular F-actin arrays in vivo.
　 Although dynamin1 was originally identiﬁed as a 
microtubule-binding protein [13],  and its GTPase 
activity was stimulated by microtubules [16,  55] as 
mentioned,  the physiological signiﬁcance of the inter-
action in the cell remained to be clariﬁed.  In mitotic 
cells,  dynamin 2 was concentrated at the microtubule 
bundle at the spindle midzone and the intercellular 
bridge in cytokinesis [56].  The middle domain of 
dynamin 2 binds to γ-tubulin,  and they colocalize at 
the centrosome,  where dynamin 2 is thought to play a 
role in centrosome cohesion [24].  Consistent with 
these observations during mitosis,  dynamin is enriched 
in spindle midbody extracts [56].
Novel Role of Dynamin in Microtubule 
Dynamics
　 We recently reported that dynamin 2 regulates the 
dynamic instability of microtubules [8].  The structure 
and dynamics of microtubules are described in other 
reviews [57-59].  Brieﬂy,  a microtubule typically 
comprises 13 protoﬁlaments,  which form the wall of a 
tube.  Each of the protoﬁlaments consists of α/β 
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tubulin heterodimers.  GTP-bound tubulin is added 
onto the plus-tips of microtubules,  and the hydrolysis 
of GTP induces conformational change in the tubulin 
dimer,  which causes microtubule depolymerization.  
This dynamic instability of microtubules is regulated 
by many factors [60].
　 As mentioned above,  dynamin was originally identi-
ﬁed as a microtubule-associated protein,  but its bio-
logical signiﬁcance remained unclear.  We found that 
dynamin 2 was localized onto microtubules in vivo,  
suggesting that dynamin has a role in the regulation of 
microtubules.  In dynamin 2-depleted cells,  no appar-
ent alteration at “bulk” microtubules was found in 
“ﬁxed cells. ” Interestingly,  however,  acetylated 
tubulin and de-tyrosinated tubulin,  which are markers 
of stable microtubules,  were signiﬁcantly increased.  
Using live cell imaging,  the dynamic instability of 
microtubules in dynamin 2-depleted cells was appar-
ently decreased compared with control cells.  
Quantitative analysis revealed that the rates of growth 
and shortening were not signiﬁcantly changed,  but the 
duration of growth and shortening was signiﬁcantly 
reduced in dynamin 2-depleted cells.  This implies that 
dynamin 2 is not required for the growth or shorten-
ing machinery itself,  but is necessary for the initiation 
or maintenance of these dynamics.
　 Next,  we examined the biological signiﬁcance of the 
dynamic instability regulated by dynamin 2.  Micro-
tubules are required for the proper localization and 
transport of intracellular organelles,  and dynamic 
instability of microtubules seems to be required for the 
search-and-capture of its target cargoes [59,  61,  
62].  The plus tips of microtubules search its cargoes 
by repetitive growing and shortening,  and when the 
plus tips encounter its cargoes,  the cargoes are caught 
and moved toward the minus end of the microtubules.  
Dysfunction of microtubule dynamics impairs organelle 
transport and subsequently induces a lack of formation 
of the Golgi and lysosomal degradation.
　 In dynamin 2-depleted cells,  both the pericentrio-
lar localization of endosomes and the formation of 
Golgi were impaired.  Recycling endosomes and Golgi 
cisternae were scattered all around the cell,  implying 
that microtubule-dependent intracellular transport was 
impaired.  Interestingly,  this was not observed by 
means of the expression of the dynamin 2-dominant 
negative mutant (K44A),  which is a GTPase-negative 
mutant.  As the expression of dynamin 2 K44A inhibits 
dynamin-dependent intracellular traﬃc,  the dynamic 
instability of microtubules regulated by dynamin 2 
seems to be independent of the GTPase activity,  and 
seems not to be a secondary eﬀect of the impairment 
of intracellular traﬃc.  Similar results have been 
reported by others in the regulation of centrioles 
[24].
　 Thus,  the major question is how dynamin regulates 
the dynamic instability of microtubules.  Although the 
molecular mechanism remains to be elucidated,  we 
illustrate the current model of the regulation of the 
dynamic instability of microtubules by dynamin in Fig.  
2.  MCAK,  a member of the kinesin-13 family,  was the 
ﬁrst identiﬁed microtubule depolymerizing factor [63,  
64].  Although MCAK is a kinesin,  it does not move 
in a directed manner on the lattice.  Rather,  MCAK 
targets by a “diﬀusion and capture” mechanism in which 
it is weakly associated with the lattice [65].  Many 
proteins were associated with microtubule polymeriza-
tion.  Of these,  the most famous polymerization factor 
is XMAP215,  and other MAPs including tau and 
doublecortin regulate polymerization [60,  66].  The 
common model of the regulation of dynamic instability 
is focused on the plus-tips of microtubules,  including 
EB1,  CLASPs and CLIP170.  We propose that 
dynamin 2 may act as a “ratchet” by rolling up the 
microtubules and may limit the range of MCAK move-
ments (Fig.  2A).  In the absence of the dynamin 
“ratchet”,  MCAK may diﬀuse all along the full-length 
microtubules,  and as a result,  ineﬃcient regulation of 
microtubule dynamics followed by accumulation of 
stable microtubules may occur (Fig.  2B).  Of course,  
as this model is not based on biochemical experiments,  
further experiments regarding the molecular mecha-
nisms are required.
Dynamin and Disease
　 Dynamin has recently been identiﬁed as a disease-
responsible gene in multiple diseases [6,  67].  In 
DI-CMT patients,  several mutations were found in the 
PH domain of dynamin 2 (Fig.  2).  The PH domain is 
responsible for the interaction with phospholipids,  
which is followed by the proper localization and/or 
activation of the proteins.  Dynamin binds speciﬁcally 
to PI(4,  5)P2 through the PH domain,  and this inter-
action is required for the localization of dynamin onto 
the membrane [68].  Thus,  the PH domain is required 
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for the proper function of dynamin,  and its deletion 
causes an endocytic defect [69].
　 Of the CMT mutants,  K558E completely blocked 
dynamin-dependent endocytosis,  as observed in a 
dominant-negative K44A mutant [8].  This suggests 
that the mutant K558E lacks interaction with PI(4,  5) 
P2.  Whereas another mutant,  551Δ3,  did not block 
dynamin-dependent endocytosis,  suggesting that the 
mutation did not aﬀect the membrane localization of 
dynamin 2.  Interestingly,  however,  internalized 
ligands were not localized around the perinuclear area 
in 551Δ3-expressing cells.  Moreover,  Golgi forma-
tion,  which depends on microtubule-dependent trans-
port,  was also disturbed by the expression of 551Δ3,  
suggesting that microtubule-dependent transport was 
impaired by the expression of 551Δ3.  As described 
above,  we found that the depletion of dynamin 2 caused 
the accumulation of stable microtubules and the 
impairment of microtubule-dependent membrane trans-
port.  The expression of 551Δ3 also induced the 
accumulation of stable microtubules,  suggesting that 
the dynamic instability of the microtubules was 
aﬀected by the mutation 551Δ3.
　 Fig.  2C illustrates a hypothetical model of abnor-
mal microtubule dynamic regulation by 551Δ3.  As 
assessed by localization analysis,  551Δ3 showed 
robust localization onto microtubules,  suggesting that 
the regulation of the localization onto microtubules 
was impaired in this mutant [8].  This abnormal local-
ization may create some limitations for the movement 
of depolymerization factors.
　 All of the dynamin mutants found in CMT disease 
was found only in dynamin 2,  not in dynamin 1.  The 
expression level of dynamin 2 is less than that of 
dynamin 1,  which is a brain-speciﬁc form.  This may 
suggest that the function related to microtubules is not 
redundant between these dynamin isoforms.  This sug-
gestion was supported by recent reports showing that 
both dynamin 1 and dynamin 2 have individual func-
tions in endocytosis,  actin reorganization and other 
processes [7,  70].  A recent report has shown that 
dynamin 1 knockout was rescued by the overexpres-
sion of dynamin 3 but not of dynamin 2 [43].  This 
clearly shows that each dynamin isoform may have a 
distinct function in the neurons.  Another possibility is 
that the major defect in DI-CMTB caused by the muta-
tion of dynamin 2 occurs in Schwann cells rather than 
in neurons.











Fig. 2　 Hypothetical models of dynamic instability of microtubules under the control of dynamin 2 and its mutant.  Dynamin 2 polymer-
izes around microtubules and undergoes polymerization/depolymerization cycles.  The microtubule depolymerization factor,  MCAK,  moves 
by lattice diﬀusion on microtubules [65].  Dynamin 2 may cause a limitation of the range of MCAK movements and induce proper dynamic 
instability of the microtubules (A).  However,  in the absence of dynamin 2,  MCAK moves freely on a broad range of microtubules,  and this 
causes a reduction in the frequency of depolymerization (B).  A CMT mutant,  551Δ3,  showed robust localization along the microtubules 
and may lack the proper polymerization or regulated depolymerization [8].  This may inhibit the localization or the movement of MCAK,  
resulting in the inhibition of microtubule depolymerization (C).
　 A point mutant,  K558E,  impaired the dynamin-
dependent endocytosis,  but another deletion mutant,  
551Δ3,  did not.  This suggests that these mutants 
impair intracellular transport at distinct steps,  that is,  
at the internalization step and at the transport step,  
respectively.  The clinical phenotypes resemble each 
other,  but are not identical in detail.  For example,  
the number of neutrophils was decreased in patients 
with the K558E mutant,  but not in those with 551Δ3 
[6].  Recently,  other dynamin mutants have been 
found in CMT type 2 [71],  which is caused by defects 
in axonal transport.  This is apparently a distinct 
phenotype from DI-CMTB,  and this discrepancy 
should be elucidated at the molecular level in future 
investigations.
　 Other dynamin 2 mutants have been found in 
patients with centronuclear myopathy,  which is char-
acterized by the concentration of the nucleus in 
multinucleated myocytes [67].  The mutations were 
concentrated in the middle domain between the 
GTPase domain and the PH domain.  This middle 
domain binds to γ-tubulin and regulates the structure 
of the centrosomes [24].  This function does not 
require GTPase activity,  as observed in the regula-
tion of microtubule dynamics.  Future study could 
reveal the molecular mechanisms between the function 
of the middle domain and the clinical phenotypes 
resulted from the mutation of the domain.
Conclusion
　 Dynamin was originally found to be a microtubule-
binding protein.  We recently found that dynamin 2 
regulates the dynamic instability of microtubules,  and 
that a mutant found in CMT patients,  551Δ3,  lacked 
the function for microtubules but not for endocytosis.  
In contrast,  another mutant,  K558E,  lacked the func-
tion for endocytosis but not for microtubules.  This 
reveals that these CMT mutants induce neuropathy by 
diﬀerent cellular mechanisms.
　 There are many genes responsible for CMT dis-
ease,  and many distinct intracellular processes are 
associated with the disease.  Dynamin 2 was identiﬁed 
as one of the CMT-responsible genes,  and there are 
some diﬀerences at the cellular level between K558E 
and 551Δ3.  The phenotypical disorders also seem to 
be slightly diﬀerent between these 2 mutations.  For 
example,  the number of neutrophils [6] was abnormal 
in patients carrying the K558E mutation,  but not in 
patients carrying the 551Δ3 mutation.  Given the cur-
rent state of knowledge about dynamin and CMT,  it is 
diﬃcult to say whether the inhibition or activation of 
dynamin would be useful for dealing with these dis-
eases.  Further elucidation of the molecular mecha-
nisms,  including dynaminʼs role on the regulation of 
microtubules,  could be required.
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